Fraunhofer ITEM staff present the final vial of the fill and finish campaign of the first larger GMP manufacturing run using an innovative cell pool technology that allowed much faster production. © Prof. Holger Ziehr

As investments into COVID-19 therapeutics is no EU priority, development is lagging behind the US. Now, CORAT Therapeutics‘ candidate COR101 is set to enter clinical testing. 

Thomas Struckmeyer will join the BioChek Group based in Reeuwijk as new CEO from mid-December. He succeeds Barend van Dam, who will assume the position of CEO of the BioChek Group.

© Tumisu/Pixabay.com

After BioNTech SE reported that its COVID-19 vaccine candidate BNT162b2 was over 90% efficient in a Phase III trial, Moderna Inc announced an efficacy of 94.5%.

Picture: ©Evotec

Evotec SE is set to expand the company’s existing campus in Milton Park/Abingdon, UK, into a major, fully-integrated drug discovery and development centre.

©Aymanejed/Pixabay.com

Pfizer and Biontech SE have reached an agreement with the European Commission to supply 200 million doses of their mRNA-based COVID-19 vaccine candidate.

Source: Global Bioeconomy Summit

More than 1,800 attendees already registered for the Global Bioeconomy Summit 2020. The conference takes place virtually from November 16 to 20. 

© BioNTech SE

Interim data on BioNtech’s/Pfizer’s COVID-19 vaccine candidate BNT162b2 suggest an efficacy of more than 90% – 30% better than required by the FDA.

Arek Socha/Pixabay.com

Swiss drugmaker Vifor Pharma has licenced US and EU commercialisation rights of Angion Biomedica’s experimental kidney drug ANG-3777.

picture: Eppendorf AG

Most Compact System for Early Stage Processes – The Eppendorf DASbox Mini Bioreactor System, with its small working volume, compact design, as well as advanced control and information management options is ideal for research and early development processes.

Claire Skentelbery, well known and connected in the European biotech community, will be the new Director General of EuropaBio. She will join the EuropaBio team at the end of November.